Dr. Marie-Sophie de Konig reviews the findings of the GIPS-IV trial, which was the first study to test the use of sodium thiosulfate for treating myocardial infarction in humans.
A First Clinical Trial Testing the Use of an H2S Donor After Heart Attack
Facebook Comments